The Federal medical-biological Agency has developed 3 sample of the vaccine against the new coronavirus. About it informs the press service of the Agency.
"Today, FMBA of Russia established on 3 sample of the vaccine, which is a recombinant proteins on the basis of surface epitopes of the S protein of SARS-CoV-2, launched studies of immunogenicity in mice," according to the report.
The results of the pilot studies expected in June, the second phase is expected to finish by the beginning of the 3rd quarter.
The latest information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.
<span style="color:darkgray
sections: Politics |